tirzepatide europe approval FDA for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly F.D.A. Approves New Obesity Drug

They [the findings] suggest that this drug class, typically used for managing diabetes and obesity, may serve as a dual-purpose treatment for patients with RA, addressing both systemic inflammation and associated comorbidities, such as cardiovascular disease, which is especially prevalent in patients with RAO and remains the leading cause of death in patients with RA overall, they said

However, current research is mostly based on in vitro validation, and its stability, targeting, and potential disease stage dependence in the real joint microenvironment remain unclear

Is Bentyl effective

It is designed to support collagen digestion and metabolic function

Supplementary Figure 3